About us Pricing ContactSubscribe

C

Cynthia Huang Bartlett

Pfizer (United States)ORCID https://orcid.org/0000-0003-2003-2213

h-index

—

Publications

—

Citations

—

i10-index

—

Impact (2-yr)

—

Top Publications

Fulvestrant plus palbociclib versus fulvestrant plus placebo for treatment of hormone-receptor-positive, HER2-negative metastatic breast cancer that progressed on previous endocrine therapy (PALOMA-3): final analysis of the multicentre, double-blind, phase 3 randomised controlled trial

The Lancet Oncology20161,795 citations

Palbociclib plus letrozole as first-line therapy in estrogen receptor-positive/human epidermal growth factor receptor 2-negative advanced breast cancer with extended follow-up

Breast Cancer Research and Treatment2019426 citations

Cynthia Huang Bartlett · Scinovex